Free Trial

Gilead Sciences (GILD) Short Interest Ratio & Short Volume

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)
Free GILD Stock Alerts
$63.94
-1.74 (-2.65%)
(As of 05/28/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends

Gilead Sciences Short Interest Data

Current Short Interest
21,700,000 shares
Previous Short Interest
21,160,000 shares
Change Vs. Previous Month
+2.55%
Dollar Volume Sold Short
$1.45 billion
Short Interest Ratio
3.2 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
1,245,850,000 shares
Float Size
1,240,000,000 shares
Short Percent of Float
1.75%
Today's Trading Volume
5,567,085 shares
Average Trading Volume
7,223,890 shares
Today's Volume Vs. Average
77%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Gilead Sciences ?

Sign up to receive the latest short interest report for Gilead Sciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GILD Short Interest Over Time

GILD Days to Cover Over Time

GILD Percentage of Float Shorted Over Time

Gilead Sciences Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202421,700,000 shares $1.45 billion +2.6%1.8%3.2 $67.01
4/30/202421,160,000 shares $1.38 billion -0.1%N/A2.9 $65.20
4/15/202421,180,000 shares $1.43 billion -6.2%N/A2.9 $67.75
3/31/202422,570,000 shares $1.65 billion +17.3%N/A3 $73.25
3/15/202419,250,000 shares $1.42 billion -2.1%1.6%2.7 $73.69
2/29/202419,670,000 shares $1.42 billion -1.1%1.6%2.7 $72.10
2/15/202419,880,000 shares $1.46 billion +27.0%1.6%2.8 $73.37
1/31/202415,660,000 shares $1.23 billion -8.6%1.3%2.2 $78.26
1/15/202417,140,000 shares $1.48 billion +0.6%1.4%2.6 $86.38
12/31/202317,040,000 shares $1.38 billion -7.9%N/A2.7 $81.01
12/15/202318,500,000 shares $1.49 billion +6.2%N/A3 $80.33
11/30/202317,420,000 shares $1.33 billion -3.9%N/A3 $76.60
11/15/202318,130,000 shares $1.36 billion -7.0%N/A3.3 $75.04
10/31/202319,500,000 shares $1.53 billion -4.2%1.6%3.6 $78.54
10/15/202320,350,000 shares $1.58 billion +0.5%1.6%3.9 $77.65
9/30/202320,240,000 shares $1.52 billion +10.4%1.6%3.8 $74.94
9/15/202318,330,000 shares $1.39 billion +0.4%1.5%3.3 $75.67
8/31/202318,250,000 shares $1.40 billion -7.0%1.5%3.2 $76.48
8/15/202319,630,000 shares $1.56 billion +4.2%1.6%3.4 $79.64
7/31/202318,840,000 shares $1.43 billion +7.2%N/A3.3 $76.14
7/15/202317,570,000 shares $1.36 billion +1.3%N/A3 $77.19
6/30/202317,340,000 shares $1.34 billion +6.3%N/A3.2 $77.07
6/15/202316,320,000 shares $1.29 billion +6.8%N/A3 $79.00
5/31/202315,280,000 shares $1.18 billion -15.0%N/A2.7 $76.94
5/15/202317,980,000 shares $1.41 billion -6.7%N/A3.4 $78.38
4/30/202319,280,000 shares $1.59 billion +26.4%N/A3.4 $82.21
4/15/202315,250,000 shares $1.27 billion -1.5%N/A2.6 $83.00
3/31/202315,480,000 shares $1.28 billion +1.8%N/A2.6 $82.97
3/15/202315,200,000 shares $1.21 billion -2.9%N/A2.5 $79.65
2/28/202315,660,000 shares $1.26 billion -0.6%N/A2.3 $80.53
2/15/202315,760,000 shares $1.34 billion +3.9%N/A2.3 $85.05
1/31/202315,170,000 shares $1.27 billion +1.6%N/A2.1 $83.94
1/15/202314,930,000 shares $1.29 billion -8.0%N/A1.9 $86.27
12/30/202216,220,000 shares $1.39 billion +9.9%N/A2.1 $85.85
12/15/202214,760,000 shares $1.28 billion -16.0%N/A1.8 $86.58
11/30/202217,560,000 shares $1.54 billion -15.3%N/A2.1 $87.83
11/15/202220,730,000 shares $1.72 billion +8.7%N/A2.5 $83.00
10/31/202219,070,000 shares $1.50 billion +15.8%N/A2.4 $78.46
10/15/202216,470,000 shares $1.09 billion +0.1%N/A2.3 $66.17
9/30/202216,450,000 shares $1.01 billion -1.4%N/A2.4 $61.69
Next President (Not Trump. Not Biden.) (Ad)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.
9/15/202216,690,000 shares $1.08 billion -0.5%N/A2.5 $65.00
8/31/202216,770,000 shares $1.06 billion -1.6%N/A2.5 $63.47
8/15/202217,040,000 shares $1.13 billion +20.3%N/A2.5 $66.21
7/31/202214,160,000 shares $846.06 million -14.5%N/A2 $59.75
7/15/202216,560,000 shares $1.04 billion +13.0%N/A2.2 $62.60
6/30/202214,650,000 shares $905.52 million -6.4%N/A1.9 $61.81
6/15/202215,650,000 shares $913.80 million +6.6%N/A1.9 $58.39
5/31/202214,680,000 shares $952.00 million -12.9%N/A1.7 $64.85
5/15/202216,850,000 shares $1.05 billion +0.9%N/A1.7 $62.37
4/30/202216,700,000 shares $990.98 million +8.7%N/A1.6 $59.34
4/15/202215,370,000 shares $950.17 million +6.3%N/A1.4 $61.82
3/31/202214,460,000 shares $859.65 million -2.6%N/A1.3 $59.45
3/15/202214,840,000 shares $865.47 million -20.3%N/A1.4 $58.32
2/28/202218,630,000 shares $1.13 billion -16.2%N/A1.9 $60.40
2/15/202222,240,000 shares $1.36 billion -7.9%N/A2.3 $61.33
1/31/202224,150,000 shares $1.66 billion +10.4%N/A2.9 $68.68
1/15/202221,880,000 shares $1.57 billion +2.7%N/A0 $71.77
12/31/202121,300,000 shares $1.55 billion -4.1%N/A3 $72.61
12/15/202122,200,000 shares $1.58 billion +1.4%N/A3.2 $71.21
11/30/202121,890,000 shares $1.51 billion -5.3%N/A3.2 $68.93
11/15/202123,120,000 shares $1.55 billion +5.5%N/A3.5 $67.20
10/29/202121,920,000 shares $1.42 billion -8.7%N/A3.4 $64.88
10/15/202124,010,000 shares $1.62 billion -1.1%N/A3.8 $67.63
9/30/202124,280,000 shares $1.70 billion +16.2%N/A3.9 $69.85
9/15/202120,900,000 shares $1.50 billion -6.9%N/A3.4 $71.76
8/31/202122,450,000 shares $1.63 billion -12.7%N/A3.7 $72.78
8/13/202125,700,000 shares $1.83 billion -0.1%N/A4.1 $71.16
7/30/202125,730,000 shares $1.76 billion -5.5%N/A4 $68.29
7/15/202127,220,000 shares $1.86 billion +12.3%N/A4.1 $68.30
6/30/202124,230,000 shares $1.67 billion +0.9%N/A3.5 $68.86
6/15/202124,020,000 shares $1.64 billion +1.4%N/A3.4 $68.09
5/28/202123,690,000 shares $1.57 billion -7.9%N/A3.2 $66.11
5/14/202125,720,000 shares $1.77 billion -10.2%2.1%3.3 $68.91
4/30/202128,640,000 shares $1.83 billion +10.1%2.3%3.7 $63.84
4/15/202126,010,000 shares $1.70 billion +11.0%2.1%3.4 $65.30
3/31/202123,440,000 shares $1.54 billion +4.1%1.9%2.8 $65.50
3/15/202122,520,000 shares $1.39 billion -5.5%1.8%2.4 $61.56
2/26/202123,830,000 shares $1.50 billion +3.1%1.9%2.6 $62.79
2/12/202123,110,000 shares $1.55 billion +7.1%1.9%2.6 $66.92
1/29/202121,580,000 shares $1.40 billion -3.5%1.7%2.3 $64.68
1/15/202122,370,000 shares $1.40 billion +3.7%1.8%2.3 $62.40
12/31/202021,570,000 shares $1.22 billion +22.1%1.7%2.2 $56.65
12/15/202017,670,000 shares $1.06 billion -14.8%1.4%1.9 $59.84
11/30/202020,730,000 shares $1.24 billion -4.5%1.7%2.2 $60.03
11/15/202021,710,000 shares $1.32 billion -4.4%1.7%2.3 $60.59
10/30/202022,700,000 shares $1.33 billion +10.7%1.8%2.4 $58.53
10/15/202020,500,000 shares $1.31 billion +5.9%1.6%2.1 $64.05
9/30/202019,360,000 shares $1.22 billion +7.9%1.6%2.2 $63.19
9/15/202017,950,000 shares $1.19 billion +11.0%1.4%2.1 $66.20
8/31/202016,170,000 shares $1.08 billion -14.1%1.3%1.9 $66.75
Banking Apocalypse Ahead: Secure Your Savings Today! (Ad)

During and after the Great Financial Crisis of 2008, 485 U.S. banks went under. We warned about 484 — an accuracy rate of 99.8% Now, I have a new warning.

See what it is here!
8/14/202018,830,000 shares $1.29 billion -11.7%1.5%2 $68.50
7/31/202021,330,000 shares $1.48 billion -3.4%1.7%2.2 $69.53
7/15/202022,090,000 shares $1.69 billion -3.7%1.8%1.7 $76.65
6/30/202022,930,000 shares $1.76 billion -9.1%1.8%1.4 $76.94
6/15/202025,220,000 shares $1.87 billion +4.5%2.0%1.4 $73.97
5/29/202024,140,000 shares $1.88 billion -7.5%1.9%1.1 $77.83
5/15/202026,090,000 shares $1.99 billion +8.2%2.1%1.1 $76.26
4/30/202024,110,000 shares $2.03 billion +6.9%1.9%1 $84.00
4/15/202022,550,000 shares $1.68 billion -4.6%1.8%1 $74.63
3/31/202023,640,000 shares $1.88 billion -11.1%1.9%1.2 $79.64
3/13/202026,584,200 shares $1.95 billion +11.9%2.1%1.1 $73.51
2/28/202023,760,000 shares $1.73 billion +10.2%1.9%1.6 $72.61
2/14/202021,560,000 shares $1.56 billion +4.7%1.7%1.9 $72.34
1/31/202020,590,000 shares $1.54 billion +15.8%1.6%2.2 $74.70
1/15/202017,780,000 shares $1.20 billion -16.5%1.4%2.4 $67.76
12/31/201921,300,000 shares $1.35 billion +32.8%1.7%3.3 $63.15

GILD Short Interest - Frequently Asked Questions

What is Gilead Sciences' current short interest?

Short interest is the volume of Gilead Sciences shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 21,700,000 shares of GILD short. 1.75% of Gilead Sciences' shares are currently sold short. Learn More on Gilead Sciences' current short interest.

What is a good short interest ratio for Gilead Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GILD shares currently have a short interest ratio of 3.0. Learn More on Gilead Sciences's short interest ratio.

Which institutional investors are shorting Gilead Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gilead Sciences: Walleye Trading LLC, Jane Street Group LLC, PEAK6 Investments LLC, Twin Tree Management LP, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Simplex Trading LLC, IMC Chicago LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Gilead Sciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.75% of Gilead Sciences' floating shares are currently sold short.

Is Gilead Sciences' short interest increasing or decreasing?

Gilead Sciences saw a increase in short interest in May. As of May 15th, there was short interest totaling 21,700,000 shares, an increase of 2.6% from the previous total of 21,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Gilead Sciences' float size?

Gilead Sciences currently has issued a total of 1,245,850,000 shares. Some of Gilead Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gilead Sciences currently has a public float of 1,240,000,000 shares.

How does Gilead Sciences' short interest compare to its competitors?

1.75% of Gilead Sciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Gilead Sciences: Seagen Inc. (5.10%), Biogen Inc. (2.41%), Neurocrine Biosciences, Inc. (1.85%), Bio-Techne Co. (4.26%), Qiagen (1.39%), Repligen Co. (8.38%), CRISPR Therapeutics AG (18.05%), Denali Therapeutics Inc. (8.09%), Amgen Inc. (1.92%), Moderna, Inc. (6.36%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Gilead Sciences stock?

Short selling GILD is an investing strategy that aims to generate trading profit from Gilead Sciences as its price is falling. GILD shares are trading down $1.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Gilead Sciences?

A short squeeze for Gilead Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GILD, which in turn drives the price of the stock up even further.

How often is Gilead Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GILD, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:GILD) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners
The #1 Crypto That You Don’t Own… Yet
Crypto 101 Media
You won't believe what Citigroup just did to it's depositors
American Alternative
4 Cryptos BETTER than Bitcoin
True Market Insiders
He Is Giving Away Bitcoin
Crypto Swap Profits
Write this ticker symbol down…
StocksToTrade
Bill Clinton Backing Biden Replacement???
The Freeport Society
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem
Weiss Ratings